Herbert J Conrad
CIK 1218815 · View on SEC EDGAR ↗
First SEC filing: March 16, 2015 · Latest: March 16, 2015
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 25, 2026 | CLDX | A | 26,000 | — | — | 26,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 16, 2022 | CLDX | A | 13,600 | — | — | 13,600 Direct | — | Acquired | (price as of 2026-08-19) |
| June 17, 2021 | CLDX | A | 12,000 | — | — | 12,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 18, 2020 | CLDX | A | 11,000 | — | — | 11,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 19, 2019 | CLDX | A | 4,500 | — | — | 4,500 Direct | — | Acquired | (price as of 2026-08-19) |
| June 19, 2018 | ABUS | A | 22,000 | — | — | 22,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 13, 2018 | CLDX | A | 67,000 | — | — | 67,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 21, 2017 | ABUS | A | 22,000 | — | — | 22,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 15, 2017 | CLDX | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 15, 2017 | CLDX | A | 10,000 | — | — | 38,500 Direct | +35.09% | Acquired | (price as of 2026-08-19) |
| June 8, 2016 | CLDX | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 8, 2016 | CLDX | A | 10,000 | — | — | 28,500 Direct | +54.05% | Acquired | (price as of 2026-08-19) |
| June 3, 2016 | ABUS | A | 7,500 | — | — | 7,500 Direct | — | Acquired | (price as of 2026-08-19) |
| Aug. 12, 2015 | ABUS | A | 7,500 | — | — | 7,500 Direct | — | Acquired | (price as of 2026-08-19) |
| June 10, 2015 | CLDX | A | 10,300 | — | — | 10,300 Direct | — | Acquired | (price as of 2026-08-19) |
| June 10, 2015 | CLDX | A | 6,500 | — | — | 18,500 Direct | +54.17% | Acquired | (price as of 2026-08-19) |
| March 30, 2015 | ABUS | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 4, 2014 | CLDX | A | 2,000 | — | — | 2,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 4, 2014 | CLDX | A | 2,000 | — | — | 12,000 Direct | +20.00% | Acquired | (price as of 2026-08-19) |
| June 19, 2013 | CLDX | A | 2,000 | — | — | 2,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 19, 2013 | CLDX | A | 2,000 | — | — | 10,000 Direct | +25.00% | Acquired | (price as of 2026-08-19) |
| June 20, 2012 | CLDX | A | 2,000 | — | — | 8,000 Direct | +33.33% | Acquired | (price as of 2026-08-19) |
| June 22, 2011 | CLDX | A | 2,000 | — | — | 2,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Sept. 22, 2010 | CLDX | A | 2,000 | — | — | 2,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Dec. 23, 2009 | CLDX | A | 2,000 | — | — | 2,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Sept. 25, 2008 | CLDX | A | 12,000 | — | — | 12,000 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 25, 2026 | CLDX | Non-Qualified Stock Option (right to buy) [F1] | Common Stock (26,000) | $34.09 | June 25, 2036 | 26,000 | Acquired |
| June 16, 2022 | CLDX | Non-Qualified Stock Option (right to buy) [F1] | Common Stock (13,600) | $22.48 | June 16, 2032 | 13,600 | Acquired |
| June 17, 2021 | CLDX | Non-Qualified Stock Option (right to buy) [F1] | Common Stock (12,000) | $28.00 | June 17, 2031 | 12,000 | Acquired |
| June 18, 2020 | CLDX | Non-Qualified Stock Option (right to buy) [F1] | Common Stock (11,000) | $10.38 | June 18, 2030 | 11,000 | Acquired |
| June 19, 2019 | CLDX | Non-Qualified Stock Option (right to buy) [F1] | Common Stock (4,500) | $2.78 | June 19, 2029 | 4,500 | Acquired |
| June 19, 2018 | ABUS | Director Stock Option (Right to Buy) | Common Shares (22,000) | $6.75 | June 19, 2028 | 22,000 | Acquired |
| June 13, 2018 | CLDX | Non-Qualified Stock Option (right to buy) [F1] | Common Stock (67,000) | $0.60 | June 13, 2028 | 67,000 | Acquired |
| June 21, 2017 | ABUS | Director Stock Option Grant (Right to Buy) | Common Shares (22,000) | $3.55 | June 21, 2027 | 22,000 | Acquired |
| June 15, 2017 | CLDX | Non-Qualified Stock Option (right to buy) [F2] | Common Stock (15,000) | $2.32 | June 15, 2027 | 15,000 | Acquired |
| June 8, 2016 | CLDX | Non-Qualified Stock Option (right to buy) [F2] | Common Stock (15,000) | $4.72 | June 8, 2026 | 15,000 | Acquired |
| June 3, 2016 | ABUS | Director Stock Option (Right to Buy) | Common Shares (7,500) | $3.99 | June 3, 2026 | 7,500 | Acquired |
| Aug. 12, 2015 | ABUS | Stock Option (Right to Buy) | Common Shares (7,500) | $9.11 | Aug. 12, 2025 | 7,500 | Acquired |
| June 10, 2015 | CLDX | Non-Qualified Stock Option (right to buy) [F2] | Common Stock (10,300) | $25.41 | June 10, 2025 | 10,300 | Acquired |
| March 30, 2015 | ABUS | Stock Option (right to buy) | Common shares (15,000) | $17.57 | March 30, 2025 | 15,000 | Acquired |
| June 4, 2014 | CLDX | Non-Qualified Stock Option (right to buy) [F2] | Common Stock (2,000) | $13.45 | June 4, 2024 | 2,000 | Acquired |
| June 19, 2013 | CLDX | Non-Qualified Stock Option (right to buy) [F2] | Common Stock (2,000) | $15.20 | June 19, 2023 | 2,000 | Acquired |
| Sept. 25, 2008 | CLDX | Non-Qualified Stock Option (right to buy) [F1] | Common Stock (12,000) | $11.65 | Sept. 25, 2018 | 12,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.